Skip to main content
Back to Journal Club
Anxiolytics in Mohs Micrographic Surgery - RCT: Efficacy & Safety

Guo D, Zloty DM, Kossintseva I.
Dermatol Surg (2023)

JC: December 2023

This randomized controlled trial evaluated the efficacy and safety of anxiolytics administered during Mohs micrographic surgery. The study assessed the impact of pharmacologic anxiolysis on patient anxiety levels, satisfaction, and procedural outcomes during Mohs surgery, where patients often experience significant wait-time anxiety between stages.

Take-Home Messages

  • •Anxiolytic administration during Mohs surgery can significantly reduce patient-reported anxiety without compromising safety.
  • •Wait-time anxiety between Mohs stages is a major source of patient distress that can be pharmacologically addressed.
  • •Careful patient selection and monitoring are essential when administering anxiolytics in the outpatient surgical setting.
PubMed →DOI →

Topic

Patient Communication

Shared decision-making, patient satisfaction, health literacy

Abstract

Patient anxiety can complicate surgical outcomes by elevating blood pressure, increasing the need for postoperative pain management, and reducing overall patient satisfaction. Despite the use of anxiolytic medications in outpatient procedures, there is limited comparative evidence on the efficacy and safety of these agents in Mohs micrographic surgery. To compare the effectiveness and safety of different preprocedural anxiolytic agents in Mohs surgery on perioperative patient anxiety and pati...

View on PubMedDOI
Literature review only. This summary is an editorial interpretation and may not reflect the complete findings of the original publication. Always refer to the full-text article for clinical decision-making.